Found: 6
Select item for more details and to access through your institution.
Diffusion Weighted Whole Body MRI for Evaluation of Early Response in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e118, doi. 10.1016/j.clml.2017.03.214
- By:
- Publication type:
- Article
Hyperammonemic Encephalopathy as Initial Presentation of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e102, doi. 10.1016/j.clml.2017.03.185
- By:
- Publication type:
- Article
Infections in Multiple Myeloma: An Understimate Risk Factor of Comorbidity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e30, doi. 10.1016/j.clml.2017.03.051
- By:
- Publication type:
- Article
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01025-7
- By:
- Publication type:
- Article
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 125, doi. 10.1007/s00277-023-05443-8
- By:
- Publication type:
- Article